Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis. 1987

M K Chan, and P Y Chau, and W W Chan
Department of Medicine, University of Hong Kong, Queen Mary Hospital.

Pharmacokinetics of ofloxacin (OFX) was studied in patients on continuous ambulatory peritoneal dialysis (CAPD) carrying out three exchanges per day. In 11 patients given 300 mg of OFX orally, serum OFX concentration peaked at 2.44 mg/l 3.7 hours after administration and the mean elimination half-life of OFX was 25 hours. OFX concentrations in peritoneal fluid underwent cyclical changes with each change of solutions, reaching beyond 0.5 mg/l after 2 hours of equilibration. There was a highly significant correlation between corresponding serum and peritoneal fluid concentrations of OFX after an 8 h equilibration (r = 0.85, p less than 0.001). In 5 patients given a 400 mg loading dose followed by 200 mg of OFX per day for 7 days, trough serum OFX concentrations ranged from 1.35 to 7.00 mg/l and no adverse effects were noticed. CAPD per exchange removed less than 2% of the total dose of OFX given.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

M K Chan, and P Y Chau, and W W Chan
January 1986, Nephron,
M K Chan, and P Y Chau, and W W Chan
September 1984, British journal of clinical pharmacology,
M K Chan, and P Y Chau, and W W Chan
January 1986, European journal of clinical pharmacology,
M K Chan, and P Y Chau, and W W Chan
January 1981, Clinical and experimental dialysis and apheresis,
M K Chan, and P Y Chau, and W W Chan
January 1987, European journal of clinical pharmacology,
M K Chan, and P Y Chau, and W W Chan
March 1985, Clinical nephrology,
M K Chan, and P Y Chau, and W W Chan
October 1996, Clinical pharmacokinetics,
M K Chan, and P Y Chau, and W W Chan
September 1987, The American journal of cardiology,
M K Chan, and P Y Chau, and W W Chan
February 1988, Antimicrobial agents and chemotherapy,
M K Chan, and P Y Chau, and W W Chan
July 1992, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!